Category Archives: Strategy

Drug Utilization Under Managed Medicaid

By Ben Comer | Published: April 4, 2013

Cash-strapped states are shifting patients from traditional fee-for-service Medicaid coverage to managed Medicaid plans. The IMS Institute of Healthcare Informatics took an early look at how this trend effects prescription drug utilization.

Posted in Strategy | Tagged CMS, Congress, drug utilization, economic stimulus, fee-for-service, IMS Health, managed Medicaid, Medicaid, States | Leave a comment

The Patent Black Label: Six Side-Effects of India's Novartis Glivec Ruling

By William Looney | Published: April 3, 2013

Monday’s decision by India’s Supreme Court to deny a patent for the top-selling oncologic drug Glivec took nearly a decade of litigation to resolve – but the implications in and beyond India are both immediate and lasting. Here’s a list of six that Pharm Exec thinks are most important:

Also posted in Emerging Markets, Global, IP, Legal, Manufacturing, Market Access, pricing | Tagged China, Glivec, Global IP, india, Novartis, oncologics, Patent, Supreme Court, TRIPs | 6 Comments

Marketing: Harnessing the Power of 'Pull'

By Guest Blogger | Published: April 3, 2013

Pull marketing – rethinking channel building A big problem Since the early days of the internet, we’ve been busy creating websites and other digital channels. It’s not an exaggeration to say that most pharmaceutical companies already have hundreds of websites and still more are coming. And now everybody is building apps. There’s a lot of activity here and in many ways [...]

Also posted in Europe, Global, Guest Blog, Marketing | Tagged Marketing, pull marketing, Sales, sales forces effectiveness | Leave a comment

For Becton Dickinson, Medication Errors are a Business Opportunity

By Ben Comer | Published: April 1, 2013

Over the next few years, med tech company Becton Dickinson will launch up to 30 generic, pre-filled syringes in an attempt to lower medication errors and raise company revenues, according to BD Rx president Mark Sebree. One man’s goof is another man’s growth, potentially.

Also posted in FDA, Manufacturing, R&D, Safety, Technology, pricing | Tagged Becton Dickinson and Company, Medical Devices, medical supplies, medication error, payers, pre-filled syringes | Leave a comment

FTC v. Actavis: The Wrong End of the Telescope

By Guest Blogger | Published: March 25, 2013

by Traci Medford-Rosow and Peter C. Richardson On December 8, 2012, the Supreme Court agreed to hear the Federal Trade Commission (FTC) v. Actavis, Inc. case. The court’s grant of certiorari marked the latest chapter in a decade-long effort by the FTC to have the court rule on the festering issue of whether pay-for-delay provisions in [...]

Also posted in IP, Legal, Market Access, Op-Ed, Regulatory | Tagged Hatch-Waxman, pay-for-delay | 1 Comment